A retrospective cohort study to determine efficacy and safety of direct anticoagulants when compared with warfarin after receiving prosthetic valve replacement
Latest Information Update: 10 Jul 2020
Price :
$35 *
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary) ; Warfarin
- Indications Myocardial infarction; Stroke; Thromboembolism; Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 10 Jul 2020 New trial record
- 30 Jun 2020 Results published in the Clinical Drug Investigation